New York drugmaker Pfizer and Mainz, Germany, immunotherapy company BioNTech said the European Commission, which generally follows CHMP's advice, will now review the recommendation, with a final ...

One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.